The British Menopause Society turned its 35th annual scientific conference into a 12-hour on-demand package, available from 7 July to 7 October 2026, and framed it as "The menopause landscape: pathways to better care." The conference itself took place on 23 July 2026. For perimenopausal women in UK primary care, that is the signal to watch: not a wholesale reset, but tighter diagnosis, more structured HRT conversations and clearer decisions about when symptoms should be reassured, investigated or referred.
The society described the event as "an outstanding and comprehensive programme" led by UK and international specialists. Its on-demand version was hosted on the CrowdComms platform, where delegates could access recorded session videos, lecture slides and an electronic Delegate Handbook. The BMS gave the package 12 hours of CPD, which shows the society is treating menopause education as ongoing professional training, not a one-off conference day.
That matters because the symptoms pushing women into GP surgeries are often non-specific and overlap with other conditions. The notes around the conference point to sleep disruption, anxiety, headaches, heavy bleeding, brain fog, palpitations, joint pain and vasomotor symptoms as the presentations clinicians need to recognise earlier, especially when they appear before periods have fully stopped. The practical debates that usually shape BMS teaching are the ones patients feel fastest: HRT selection, risk communication, tailoring treatment to symptoms and comorbidities, and dealing with myths that still affect access to care.
The wider education calendar shows how active this field has become. The BMS listed the Menopause Society of Ireland Annual Conference for 12 September 2026 in Dublin Royal Convention Centre and the WHC 36th Annual Symposium for 13 October 2026 at the Cavendish Conference Centre in London. Put together, those dates show menopause education running as a continuous professional circuit across the UK and Ireland, with the BMS at its centre.
The commercial stakes are wider than the conference room. Menopause care now spans NHS pathways, private clinics, digital health providers, pharmacies, testing companies and employers building workplace policies. When the BMS stages its annual scientific conference and packages it for later viewing, it is helping set the evidence base that often reaches patients next through the language a GP uses, the options offered and the threshold for investigation or referral.